Scope

Swiss based – world focused

The Novo Nordisk Haemophilia Foundation (NNHF) is based in Zurich, Switzerland, with world-wide activities focused on improving haemophilia care and treatment.

The geographical scope of NNHF is towards countries in the OECD Development Assistance Committee (OECD DAC) list* defined as developing but excluding the least developed countries. Furthermore, NNHF is also active in the so-called transition countries, i.e. those countries recently joining the European Union or intending to do so in the near future. In these countries, there is typically some level of haemophilia treatment, which forms the basis for support by NNHF.

NNHF cooperates with partners in these countries, such as health ministries and authorities, non governmental and patient organisations, health care professionals, other foundations and trusts.

*You need adobe acrobat reader®, in order to see this document. Click here to obtain Adobe Acrobat Reader®.